Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second Generation Antipsychotic Induced Metabolic Adverse Effects”

3 trials

Showing 3 of 3 results

Not applicableUnknownNCT04395326
What this trial is testing

Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population

Who this might be right for
Adverse Drug Event
St. Justine's Hospital 120
Post-approval studies (Phase 4)Study completedNCT01811160
What this trial is testing

Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

Who this might be right for
Second Generation Antipsychotic Induced Metabolic Adverse Effects
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente 50
Not applicableUnknownNCT02964923
What this trial is testing

Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Xijing Hospital 300

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation